Home > News > Intellectual Property: Patent or Padlock: Patents and Trade Secrets Form the Heart of an Effective IP Strategy
February 2nd, 2007
Intellectual Property: Patent or Padlock: Patents and Trade Secrets Form the Heart of an Effective IP Strategy
Abstract:
The intellectual property (IP) of a company is often its core asset. Acquiring, protecting, and enforcing IP involves decisions at the highest levels of the company, and IP commands a significant portion of the company's resources. For most life sciences companies, patents are usually considered to be the principle IP asset. In practice, however, these companies usually have extensive know-how, most often kept as trade secrets. If a direct comparison could be made, a typical life-sciences company probably keeps more than two-thirds of its proprietary information in the form of trade secrets. In early stage companies, particularly in relatively new technology areas such as nanotechnology, the proportion of trade secrets to patents is much higher.
Source:
biopharm-mag.com
Bookmark:
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals
Heinrich Rohrer dies at 79; a father of nanotechnology: With IBM colleague Gerd Binnig, Rohrer invented the scanning tunneling microscope, which can show individual atoms on a surface and move them around May 23rd, 2013
IDTechEx launches online Market Intelligence Portal May 23rd, 2013
Whirlpools on the Nanoscale Could Multiply Magnetic Memory: At the Advanced Light Source, Berkeley Lab scientists join an international team to control spin orientation in magnetic nanodisks May 22nd, 2013
UofL scientists uncover how grapefruits provide a secret weapon in medical drug delivery May 22nd, 2013
Patents/IP/Tech Transfer/Licensing
Innovation could bring flexible solar cells, transistors, displays May 22nd, 2013
NanoInk, Inc. Assets To Be Sold May 18th, 2013
HELIOS Program Develops Complete Supply Chain for Integrating Photonics with CMOS Circuit via IC Fabrication Processes May 14th, 2013
Nanotechnology Pioneer Named 'Entrepreneur of the Year': Royal Society of Chemistry honors Chad Mirkin for commercializing innovations May 10th, 2013